Bank of Nova Scotia’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Buy
16,399
+1,196
+8% +$145K ﹤0.01% 803
2026
Q1
$2.49M Sell
15,203
-45,572
-75% -$7.01M ﹤0.01% 707
2025
Q4
$10.6M Sell
60,775
-445,470
-88% -$81.3M 0.02% 465
2025
Q3
$72.9M Buy
+506,245
New +$62M 0.13% 129

Other funds holding INSM

Bank of Nova Scotia's INSM Position: Q2 2026 in Review

Bank of Nova Scotia increased its Insmed (INSM) stake by 7.9% in Q2 2026, buying an estimated $145K and bringing the position to 16,399 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #803.

Bank of Nova Scotia first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $72.9M in Q3 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Bank of Nova Scotia held 16,399 shares of Insmed worth $1.75M as of Q2 2026.
  • Bank of Nova Scotia bought 1,196 Insmed shares in Q2 2026, an estimated $145K.
  • Insmed made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q2 2026, its #803 holding.
  • Bank of Nova Scotia first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • Bank of Nova Scotia's Insmed position peaked at $72.9M in Q3 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.